Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (688505) — Free Cash Flow Generation Index
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (688505) has a Free Cash Flow Generation Index of 0.92x as of September 2025. Free cash flow of CN¥40.13 Million represents 1% of operating cash flow (CN¥43.77 Million). Explore Shanghai Fudan-Zhangjiang Bio-Pharmaceut capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd Free Cash Flow Generation Index (2009–2025)
Historical FCF Generation Index trend for Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd across 15 annual periods. For the full cash flow conversion analysis, see Shanghai Fudan-Zhangjiang Bio-Pharmaceut cash flow conversion.
Annual Free Cash Flow Generation for Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (2009–2025)
Year-by-year Free Cash Flow Generation Index for Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd. Check Shanghai Fudan-Zhangjiang Bio-Pharmaceut investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.77x | CN¥109.03 Million | CN¥141.40 Million | CN¥32.37 Million | ▲ +295.9% |
| 2023 | -0.39x | CN¥-27.95 Million | CN¥71.02 Million | CN¥98.97 Million | ▼ -183.4% |
| 2022 | 0.47x | CN¥77.96 Million | CN¥165.27 Million | CN¥87.30 Million | ▼ -14.7% |
| 2021 | 0.55x | CN¥148.78 Million | CN¥268.90 Million | CN¥120.12 Million | ▼ -11.4% |
| 2020 | 0.62x | CN¥70.59 Million | CN¥113.00 Million | CN¥42.41 Million | ▼ -26.5% |
| 2019 | 0.85x | CN¥228.85 Million | CN¥269.23 Million | CN¥40.39 Million | ▲ +8.6% |
| 2018 | 0.78x | CN¥136.15 Million | CN¥173.94 Million | CN¥37.79 Million | ▲ +283.4% |
| 2017 | -0.43x | CN¥-18.23 Million | CN¥42.71 Million | CN¥60.94 Million | ▼ -164.0% |
| 2016 | 0.67x | CN¥93.75 Million | CN¥140.57 Million | CN¥46.82 Million | ▲ +13.6% |
| 2015 | 0.59x | CN¥56.55 Million | CN¥96.30 Million | CN¥39.75 Million | ▲ +19.4% |
| 2014 | 0.49x | CN¥43.45 Million | CN¥88.36 Million | CN¥44.91 Million | ▲ +37.2% |
| 2013 | 0.36x | CN¥32.07 Million | CN¥89.44 Million | CN¥57.38 Million | ▲ +976.7% |
| 2012 | -0.04x | CN¥-4.51 Million | CN¥110.19 Million | CN¥114.69 Million | ▼ -112.2% |
| 2011 | 0.33x | CN¥16.60 Million | CN¥49.59 Million | CN¥32.99 Million | ▲ +105.4% |
| 2009 | -6.23x | CN¥-48.09 Million | CN¥7.72 Million | CN¥55.82 Million | — |